A mouse model of severe von Willebrand disease:: Defects in hemostasis and thrombosis

被引:421
作者
Denis, C
Methia, N
Frenette, PS
Rayburn, H
Ullman-Culleré, M
Hynes, RO
Wagner, DD
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[4] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA
[5] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA
关键词
D O I
10.1073/pnas.95.16.9524
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
von Willebrand factor (vWf) deficiency causes severe von Willebrand disease in humans. We generated a mouse model for this disease by using gene targeting. vWf-deficient mice appeared normal at birth; they were viable and fertile. Neither vWf nor vWf propolypeptide (von Willebrand antigen II) were detectable in plasma, platelets, or endothelial cells of the homozygous mutant mice. The mutant mice exhibited defects in hemostasis with a highly prolonged bleeding time and spontaneous bleeding events in approximate to 10% of neonates, As in the human disease, the factor VIII level in these mice was reduced strongly as a result of the lack of protection provided by vWf. Defective thrombosis in mutant mice was also evident in an in vivo model of vascular injury, In this model, the exteriorized mesentery was superfused with ferric chloride and the accumulation of fluorescently labeled platelets was observed by intravital microscopy, We conclude that these mice very closely mimic severe human von Willebrand disease and will be very useful for investigating the role of vWf in normal physiology and in disease models.
引用
收藏
页码:9524 / 9529
页数:6
相关论文
共 27 条
  • [1] Molecular mechanisms of platelet adhesion and activation
    Andrews, RK
    Lopez, JA
    Berndt, MC
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) : 91 - 105
  • [2] ON-LINE VOLUME FLOW-RATE AND VELOCITY PROFILE MEASUREMENT FOR BLOOD IN MICROVESSELS
    BAKER, M
    WAYLAND, H
    [J]. MICROVASCULAR RESEARCH, 1974, 7 (01) : 131 - 143
  • [3] Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies
    Bi, L
    Sarkar, R
    Naas, T
    Lawler, AM
    Pain, J
    Shumaker, SL
    Bedian, V
    Kazazian, HH
    [J]. BLOOD, 1996, 88 (09) : 3446 - 3450
  • [4] TARGETED DISRUPTION OF THE MOUSE FACTOR-VIII GENE PRODUCES A MODEL OF HEMOPHILIA-A
    BI, L
    LAWLER, AM
    ANTONARAKIS, SE
    HIGH, KA
    GEARHART, JD
    KAZAZIAN, HH
    [J]. NATURE GENETICS, 1995, 10 (01) : 119 - 121
  • [5] BOWIE EJW, 1989, COAGULATION BLEEDING, P305
  • [6] Bradley A., 1987, TERATOCARCINOMAS EMB, P113
  • [7] Ewenstein BM, 1997, ANNU REV MED, V48, P525
  • [8] GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO
  • [9] 2-H
  • [10] Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha(IIb)beta(3)
    Holmback, K
    Danton, MJS
    Suh, TT
    Daugherty, CC
    Degen, JL
    [J]. EMBO JOURNAL, 1996, 15 (21) : 5760 - 5771